At the heart of ProAxsis is the relentless pursuit in identifying key biomarkers and developing products and technologies satisfying the unmet needs of healthcare professionals across the globe. Key chronic diseases including, but not limited to, COPD, Bronchiectasis and Cystic Fibrosis, benefit from the specificity and sensitivity of ProAxsis kits whilst the services available are provided with precision and accuracy.